Publications by authors named "Vikyath Satish"
Article Synopsis
- - Acute recurrent myopericarditis is a rare condition that occurs after a symptom-free period of 4-6 weeks, with no clear management guidelines, making it difficult to understand its causes and treatment.
- - A case study of a 44-year-old man showed he had recurrent myopericarditis caused by Coxsackie A virus, diagnosed through elevated biomarkers and pericardial effusion, and he improved with colchicine and ibuprofen.
- - The recurrence of myopericarditis can happen in 15%-50% of cases and is linked to various factors, but using current treatment methods for recurrent pericarditis has led to significant symptom relief, highlighting the need for more research into
Catheter Ablation of Atrial Fibrillation in Infiltrative Cardiomyopathies: A Narrative Review.
J Cardiovasc Electrophysiol
November 2024
Atrial and ventricular arrhythmias are common in patients with Infiltrative heart diseases. This review discusses ablative techniques for arrhythmias in amyloidosis, sarcoidosis, hemochromatosis, and glycogen storage disorders, primarily focusing on atrial fibrillation (AF). A thorough literature review was conducted on the MEDLINE database to synthesize current knowledge and propose future research directions.
View Article and Find Full Text PDFArticle Synopsis
- - Embolic protection devices (EPDs) are used during percutaneous coronary interventions (PCI) to catch debris that can cause complications; this study focused on their effectiveness and safety in ST-elevation myocardial infarction (STEMI) patients without saphenous vein grafts (SVG).
- - Researchers analyzed data from three randomized controlled trials (RCTs) involving 741 patients, examining multiple outcomes including 30-day mortality and major adverse events following PCI with and without EPDs.
- - Results showed that while EPDs did not significantly affect overall mortality or other major outcomes like heart flow and ST segment resolution, they did significantly lower the incidence of detectable distal embolization.
Article Synopsis
- The study investigates the effects of beta-blocker (BB) use after a myocardial infarction (MI) in patients without heart failure or significantly reduced ejection fraction, aiming to clarify mixed findings from past research.
- Analyzing data from 24 studies involving over 290,000 patients, the research found that BB use was linked to an 11% reduction in all-cause mortality, though this result showed moderate to high variability across studies.
- Subgroup analyses indicated that while BBs provided mortality benefits in patients with a one-year event-free period, those benefits diminished over time, especially in individuals with preserved ejection fraction post-2010, where BBs showed no significant mortality reduction
Myocardial infarction with non-obstructive coronary arteries (MINOCA) refers to the occurrence of myocardial infarction symptoms and signs despite angiographic findings showing normal or near-normal coronary arteries. Unlike the more commonly recognized myocardial infarction with coronary artery disease (MICAD), MINOCA often has a better prognosis; however, it is not without risk, as it is associated with increased mortality. We present a 72-year-old female who presented to the hospital with acute chest pain.
View Article and Find Full Text PDFBackground: After a cryptogenic stroke, patients often will require prolonged cardiac monitoring; however, the subset of patients who would benefit from long-term rhythm monitoring is not clearly defined.
Objective: The purpose of this study was to create a risk score by identifying significant predictors of atrial fibrillation (AF) using age, sex, comorbidities, baseline 12-lead electrocardiogram, short-term rhythm monitoring, and echocardiographic data and to compare it to previously published risk scores.
Methods: Patients admitted to Montefiore Medical Center between May 2017 and June 2022 with a primary diagnosis of cryptogenic stroke or transient ischemic attack who underwent long-term rhythm monitoring with an implantable cardiac monitor were retrospectively analyzed.